Presence of Banned Drugs in Dietary Supplements Following FDA Recalls

被引:72
|
作者
Cohen, Pieter A. [1 ]
Maller, Gregory [2 ]
DeSouza, Renan [2 ]
Neal-Kababick, James [3 ]
机构
[1] Harvard Univ, Sch Med, Boston, MA USA
[2] Cornell Univ, Ithaca, NY USA
[3] Flora Res Labs, Grants Pass, OR USA
来源
关键词
D O I
10.1001/jama.2014.10308
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1691 / 1693
页数:3
相关论文
共 50 条
  • [21] FDA to ban sales of dietary supplements containing ephedra
    Ling, AM
    JOURNAL OF LAW MEDICINE & ETHICS, 2004, 32 (01): : 184 - 186
  • [22] FDA statutory authority to regulate the safety of dietary supplements
    Hutt, PB
    AMERICAN JOURNAL OF LAW & MEDICINE, 2005, 31 (2-3) : 155 - 174
  • [24] Regulation of dietary supplements: FDA's strategic plan
    Levitt, JA
    FOOD AND DRUG LAW JOURNAL, 2002, 57 (01) : 1 - 13
  • [25] Pharmaceutical doses of the banned stimulant oxilofrine found in dietary supplements sold in the USA
    Cohen, Pieter A.
    Avula, Bharathi
    Venhuis, Bastiaan
    Travis, John C.
    Wang, Yan-Hong
    Khan, Ikhlas A.
    DRUG TESTING AND ANALYSIS, 2017, 9 (01) : 135 - 142
  • [29] Dietary supplements, drugs and doping in the sport society
    Savino, G.
    Valenti, L.
    D'Alisera, R.
    Pinelli, M.
    Persil, Y.
    Trenti, T.
    Spica, V. Romano
    Pasquarella, C.
    Liguori, G.
    Fallace, P.
    ANNALI DI IGIENE MEDICINA PREVENTIVA E DI COMUNITA, 2019, 31 (06): : 548 - 555
  • [30] Causality assessment in hepatotoxicity by drugs and dietary supplements
    Teschke, Rolf
    Schwarzenboeck, Alexander
    Hennermann, Karl-Heinz
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (06) : 758 - 766